BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29555891)

  • 1. Teaching NeuroImages: Adult-onset vanishing white matter disease.
    Villar-Quiles RN; Delgado-Suárez C; Jorquera-Moya M; Arpa-Gutiérrez J; Ortega-Suero G
    Neurology; 2018 Mar; 90(12):e1091-e1092. PubMed ID: 29555891
    [No Abstract]   [Full Text] [Related]  

  • 2. Teaching NeuroImages: Vanishing white matter ovarioleukodystrophy.
    Mukerji SS; Eichler FS
    Neurology; 2016 Jun; 86(24):e248. PubMed ID: 27298454
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovarioleukodystrophy due to EIF2B5 mutations.
    Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM
    Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarioleukodystrophy: report of a case with the c.338G>A (p.Arg113His) mutation on exon 3 and the c.896G>A (p.Arg299His) mutation on exon 7 of the EIF2B5 gene.
    Imam I; Brown J; Lee P; Thomas PK; Manji H
    BMJ Case Rep; 2011 Mar; 2011():. PubMed ID: 22699478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia.
    Wei C; Qin Q; Chen F; Zhou A; Wang F; Zuo X; Chen R; Lyu J; Jia J
    BMC Neurol; 2019 Aug; 19(1):203. PubMed ID: 31438897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanishing white matter disease caused by EIF2B2 mutation with the presentation of an adrenoleukodystrophy phenotype.
    Alsalem A; Shaheen R; Alkuraya FS
    Gene; 2012 Apr; 496(2):141-3. PubMed ID: 22285377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spasticity and progressive ataxia due to vanishing white matter].
    Paez-Granda D; Jimenez-Sanchez A; Fernandez-Hernandez C; Serrano-Garcia C
    Rev Neurol; 2017 Dec; 65(12):563-564. PubMed ID: 29235619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel hypomorphic splice variant in EIF2B5 gene is associated with mild ovarioleukodystrophy.
    Rodríguez-Palmero A; Schlüter A; Verdura E; Ruiz M; Martínez JJ; Gourlaouen I; Ka C; Lobato R; Casasnovas C; Le Gac G; Fourcade S; Pujol A
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1574-1579. PubMed ID: 33245593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leukoencephalopathy with vanishing white matter: a clinical case of adult onset].
    Pato Pato A; Lorenzo González JR; Cimas Hernando I; Rodríguez-Constenla I
    Neurologia; 2009 Sep; 24(7):504-5. PubMed ID: 21469262
    [No Abstract]   [Full Text] [Related]  

  • 10. Adult-onset vanishing white matter disease with novel missense mutations in a subunit of translational regulator, EIF2B4.
    Kanbayashi T; Saito F; Matsukawa T; Oba H; Hokkoku K; Hatanaka Y; Tsuji S; Sonoo M
    Clin Genet; 2015 Oct; 88(4):401-3. PubMed ID: 25600065
    [No Abstract]   [Full Text] [Related]  

  • 11. Epilepsy and ovarian failure: Two cases of adolescent-onset ovarioleukodystrophy.
    Herrera-García JD; Guillen-Martínez V; Creus-Fernández C; Mínguez-Castellanos A; Carnero Pardo C
    Clin Neurol Neurosurg; 2018 Feb; 165():94-95. PubMed ID: 29331873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation.
    La Piana R; Vanderver A; van der Knaap M; Roux L; Tampieri D; Brais B; Bernard G
    Arch Neurol; 2012 Jun; 69(6):765-68. PubMed ID: 22312164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5.
    Matsukawa T; Wang X; Liu R; Wortham NC; Onuki Y; Kubota A; Hida A; Kowa H; Fukuda Y; Ishiura H; Mitsui J; Takahashi Y; Aoki S; Takizawa S; Shimizu J; Goto J; Proud CG; Tsuji S
    Neurogenetics; 2011 Aug; 12(3):259-61. PubMed ID: 21484434
    [No Abstract]   [Full Text] [Related]  

  • 14. Vanishing white matter disease with mutations in EIF2B5 gene.
    Sharma S; Ajij M; Singh V; Aneja S
    Indian J Pediatr; 2015 Jan; 82(1):93-5. PubMed ID: 25230711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanishing white matter disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an unusual early onset and a long course.
    Sambati L; Agati R; Bacci A; Bianchi S; Capellari S
    Neurol Sci; 2013 Jul; 34(7):1235-8. PubMed ID: 22729508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association between homozygous c.318A>GT mutation in exon 2 of the EIF2B5 gene and the infantile form of vanishing white matter leukoencephalopathy].
    Esmer C; Blanco Hernández G; Saavedra Alanís V; Reyes Vaca JG; Bravo Oro A
    Bol Med Hosp Infant Mex; 2017; 74(5):364-369. PubMed ID: 29382480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood--a case report and review of the literature.
    Klingelhoefer L; Misbahuddin A; Jawad T; Mellers J; Jarosz J; Weeks R; Ray Chaudhuri K
    Pediatr Neurol; 2014 Jul; 51(1):157-64. PubMed ID: 24938145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Three-dimensional Structure of eIF2B: A Clue to Understanding the Pathogenesis of CACH/VWM Disease].
    Kashiwagi K; Ito T; Yokoyama S
    Brain Nerve; 2017 Jan; 69(1):45-50. PubMed ID: 28126977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EIF2B2 gene mutation causing early onset vanishing white matter disease: a case report.
    Filareto I; Cinelli G; Scalabrini I; Caramaschi E; Bergonzini P; Spezia E; Todeschini A; Iughetti L
    Ital J Pediatr; 2022 Jul; 48(1):128. PubMed ID: 35897042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation.
    Ghezzi L; Scarpini E; Rango M; Arighi A; Bassi MT; Tenderini E; De Riz M; Jacini F; Fumagalli GG; Pietroboni AM; Galimberti D; Bresolin N
    Neurology; 2012 Nov; 79(20):2077-8. PubMed ID: 23115207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.